Aquestive Therapeutics Stock Price

0.22 (4.21%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 497,411
Bid Price 5.42
Ask Price 5.47
News -
Day High 5.57


52 Week Range


Day Low 5.11
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Aquestive Therapeutics Inc AQST NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.22 4.21% 5.45 20:00:01
Open Price Low Price High Price Close Price Prev Close
5.27 5.11 5.57 5.45 5.23
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,862 497,411 $ 5.32 $ 2,644,138 - 3.10 - 8.06
Last Trade Time Type Quantity Stock Price Currency
19:05:25 15 $ 5.45 USD


Draw Mode:

Aquestive Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 218.89M 40.16M 26.65M $ 45.85M $ - -1.66 -2.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 5.40%

more financials information »

Aquestive Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AQST Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.986.194.565.15818,721-0.53-8.86%
1 Month6.186.404.565.70616,648-0.73-11.81%
3 Months4.176.403.675.13537,2231.2830.7%
6 Months3.976.403.104.51552,7791.4837.28%
1 Year6.778.063.104.90678,493-1.32-19.5%
3 Years8.3810.001.415.37600,065-2.93-34.96%
5 Years15.0520.69611.415.69551,978-9.60-63.79%

Aquestive Therapeutics Description

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. The product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS). Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.

Your Recent History
Aquestive ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.